Literature DB >> 2479475

Sensitivity of Chinese hamster ovary mutants defective in DNA double strand break repair to topoisomerase II inhibitors.

P A Jeggo1, K Caldecott, S Pidsley, G R Banks.   

Abstract

xrs-1 is an ionizing radiation sensitive Chinese hamster ovary (CHO) strain and has a defect in double strand break rejoining. It is also highly sensitive to topoisomerase II inhibiting anticancer drugs. Sensitivity is specific for those drugs that inhibit the breakage/reunion mechanism of topoisomerase II. xrs-1 and its parent strain CHO-K1 have equal levels of topoisomerase II activity, assayed by their ability to unknot complex knotted P4 head DNA. Drug stimulated protein-DNA complex formation was similar in xrs-1 and CHO-K1, showing that they accrued equal levels of drug induced lesions. Thus sensitivity most likely results from subsequent differences in the processing of these lesions rather than the rate of formation. Drug sensitivity is directly related to the xrs phenotype since drug and gamma-ray resistance are coordinately reactivated by azacytidine treatment. All six members of the xrs complementation group are hypersensitive to etoposide. Sensitivity is not a feature common to all X-ray sensitive mutants but is shown by another complementation group, which also has a defect in double strand break rejoining. These results thus demonstrate a correlation between an inability to rejoin double strand breaks and sensitivity to topoisomerase II targeting antitumor drugs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479475

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  An antitumor drug-induced topoisomerase cleavage complex blocks a bacteriophage T4 replication fork in vivo.

Authors:  G Hong; K N Kreuzer
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Endonuclease cleavage of blocked replication forks: An indirect pathway of DNA damage from antitumor drug-topoisomerase complexes.

Authors:  George Hong; Kenneth N Kreuzer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-18       Impact factor: 11.205

3.  Progression of chromosomal damage induced by etoposide in G2 phase in a DNA-PKcs-deficient context.

Authors:  Micaela Palmitelli; Marcelo de Campos-Nebel; Marcela González-Cid
Journal:  Chromosome Res       Date:  2015-07-08       Impact factor: 5.239

4.  Molecular and biochemical characterization of xrs mutants defective in Ku80.

Authors:  B K Singleton; A Priestley; H Steingrimsdottir; D Gell; T Blunt; S P Jackson; A R Lehmann; P A Jeggo
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

5.  Intracellular clusterin negatively regulates ovarian chemoresistance: compromised expression sensitizes ovarian cancer cells to paclitaxel.

Authors:  Mohamed Kamel Hassan; Hidemichi Watari; Lane Christenson; Saverio Bettuzzi; Noriaki Sakuragi
Journal:  Tumour Biol       Date:  2011-07-15

6.  The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells.

Authors:  Michael Zeidler; Sooryanarayana Varambally; Qi Cao; Arul M Chinnaiyan; David O Ferguson; Sofia D Merajver; Celina G Kleer
Journal:  Neoplasia       Date:  2005-11       Impact factor: 5.715

7.  The DNA-damage response: new molecular insights and new approaches to cancer therapy.

Authors:  Stephen P Jackson
Journal:  Biochem Soc Trans       Date:  2009-06       Impact factor: 5.407

8.  Deoxyamphimedine, a pyridoacridine alkaloid, damages DNA via the production of reactive oxygen species.

Authors:  Kathryn M Marshall; Cynthia D Andjelic; Deniz Tasdemir; Gisela P Concepción; Chris M Ireland; Louis R Barrows
Journal:  Mar Drugs       Date:  2009-05-25       Impact factor: 5.118

Review 9.  Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.

Authors:  N J Curtin
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

10.  Hypersensitivity of Ku-deficient cells toward the DNA topoisomerase II inhibitor ICRF-193 suggests a novel role for Ku antigen during the G2 and M phases of the cell cycle.

Authors:  P Muñoz; M Z Zdzienicka; J M Blanchard; J Piette
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.